Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute for Diagnostic, Interventional and Paediatric Radiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Eur J Vasc Endovasc Surg. 2017 Nov;54(5):646-652. doi: 10.1016/j.ejvs.2017.07.017. Epub 2017 Sep 2.
The most appropriate material for reconstruction of the aorta for native or graft infection remains a matter for debate. This study examines the mid-term outcome of patients and graft durability after in situ aortic reconstruction with self made bovine pericardial tube grafts.
This was a retrospective analysis of all patients who underwent in situ aortic reconstruction using self made bovine pericardial tube grafts between January 2008 and December 2015 at a tertiary referral centre. Peri-operative and mid-term outcomes including mortality and re-infection were analysed at the end of January 2017. Available follow-up imaging was reviewed to assess graft durability.
Bovine pericardial aortic tube grafts were used in 35 patients (86% male) with a median age of 69 years (range 38-84) to reconstruct the ascending aorta or the aortic arch (7), the descending (7), the thoraco-abdominal (7), or the abdominal (14) aorta. Twelve patients (34%) were treated for infection of the native aorta and 23 (66%) for prosthetic graft infection. Twenty-two patients (63%) underwent emergency surgery. Thirty day mortality was 31% (n = 11). Additionally, six patients died during follow-up after a median of 33 months (range 3-70). For the remaining patients, mean follow-up was 48 months (± 26) with a mean Follow-Up Index of 0.98 ± 0.08. There were no readmissions or re-operations for re-infection or graft related complications. Follow-up imaging showed no signs of graft degeneration after a median of 15 months (range 3-68).
Surgical treatment of native and aortic graft or endograft infection remains high risk. Self made bovine pericardial tube grafts for in situ reconstruction are a promising option offering many advantages. Despite high early mortality rates, early radiological and mid-term clinical results are good. Definitive eradication of the infection seems feasible after in situ insertion of xeno-pericardial material for aortic repair.
对于原位或移植物感染,最适合的重建材料仍然存在争议。本研究探讨了使用自制牛心包管移植物原位重建后患者的中期结果和移植物的耐久性。
这是对 2008 年 1 月至 2015 年 12 月在一家三级转诊中心接受自制牛心包管移植物原位重建的所有患者进行的回顾性分析。在 2017 年 1 月底分析了围手术期和中期结果,包括死亡率和再感染。回顾了可用的随访影像学检查以评估移植物的耐久性。
35 例患者(86%为男性)使用牛心包管移植物,中位年龄为 69 岁(范围 38-84 岁),用于重建升主动脉或主动脉弓(7 例)、降主动脉(7 例)、胸腹主动脉(7 例)或腹主动脉(14 例)。12 例(34%)患者为治疗原发病变感染,23 例(66%)患者为治疗人造移植物感染。22 例(63%)患者行急诊手术。30 天死亡率为 31%(n=11)。此外,6 例患者在中位随访 33 个月(范围 3-70 个月)后死亡。对于其余患者,中位随访时间为 48 个月(±26),中位随访指数为 0.98±0.08。无再入院或因再感染或移植物相关并发症而再次手术。中位随访 15 个月(范围 3-68 个月)后,影像学检查未见移植物退化迹象。
治疗原发病变和主动脉移植物或内置移植物感染仍然具有高风险。使用自制牛心包管移植物原位重建是一种有前途的选择,具有许多优势。尽管早期死亡率较高,但早期影像学和中期临床结果良好。在原位插入异种心包材料修复主动脉后,似乎可以彻底消除感染。